Connect with us

Health

Walmart to Sell InnerScope’s Hearing Aids to Customers

Published

on

By Dipo Olowookere

InnerScope Hearing Technologies Inc. (INND) has announced that Walmart has successfully launched the company’s FDA-Registered Hearing Aids and its Personal Sound Amplifier Products (PSAPs) to be sold Direct-To-Consumer to Walmart’s online customers.

A statement issued by INND disclosed that as a contract supplier and a direct ship vendor aka drop ship vendor (DSV) for Walmart, it has been preparing for the launch by ramping-up multiple skews of its PSAPs and hearing aid device inventory, ready to be shipped directly to Walmart customers upon order.

The company prides itself on continuing to deliver on its mission by providing Direct-To-Consumer easy access of the latest in high quality hearing aid technology at very affordable prices.

Walmart along with InnerScope is continuing to enhance the format, language and listing for all of the company’s products on the web pages on Walmart.

These enhancements will allow Walmart’s customers to have increased visibility and understanding of the differences between each hearing product listing for ease of ordering.

InnerScope as a DSV supplier to Walmart promised to continue to add more high quality hearing aid and hearing assistive products to Walmart’s listing and web pages.

The ALPHA’s are a very small discreet compact design and comfortable with Bluetooth Low Energy (BLE) wireless technology (for direct connection to external Bluetooth-enable devices) with a user app for added user control and personalizing the hearing aids for all different environments via Android or iOS Smartphone’s. The ALPHA Series with Bluetooth and a Smart Control App is offered in 3 levels of technology based on affordability and hearing needs.

The ALPHA 3 hearing aid has a digital processor that consists of 4-channels and 8-frequency bands with 4 separated user programs. The ALPHA 3 is suitable for mild to moderately severe hearing losses and includes a Basic Instantaneous Noise and Surround Sound Processor. The APLHA 3 offers Best-Value and affordability with its basic features designed for moderately active lifestyles.

The ALPHA 5 hearing aid has a digital processor that consists of 12-channels and 16-frequency bands with 5 separated user programs. The ALPHA 5 is suitable for mild to moderately severe hearing losses and includes an Automatic Intelligent Switching for Different Environments, Advanced Instantaneous Noise and Surround Sound Processor. The APLHA 5 and its Advanced features are designed for more active lifestyles that requires hearing in many different environments.

The ALPHA 9 hearing aid has a digital processor that consists of 16-channels and 16-frequency bands with 6 separated user programs. The ALPHA 9 is suitable for mild to moderately severe hearing losses and includes Best-in-Class Automatic Intelligent Switching for Different Environments with Instantaneous Noise and Surround Sound Processor. The APLHA 9 and its Best-in-Class features are designed for the most active lifestyles that requires the best opportunity to hear clearly in the most demanding environments.

The Teeny PSAP is a patented audiologist designed ear-level PSAP which uses the same Advanced Digital Technology found in higher priced hearing aid devices. The Teeny is a one size fits all completely-in-the-canal (CIC), made to be comfortably hidden within the ear canal.

The Crescent PSAPa patented audiologist designed ear-level PSAP which also like the Teeny PSAP, uses the same Advanced Digital Technology found in higher priced hearing aid devices. The Crescent with its unique universal shell design fits approximately 95% of all ears.

The BlackCat PSAP is a hearable/wearable personal audio controller designed for people who have difficulty understanding conversation in difficult listening and noisy situations, like in a restaurant or group gatherings. Its compact credit card design and easy to use buttons for the user to control volume, balance and rear noise suppression.

“We could not have been more pleased with working with Walmart.com for helping them to promote our affordable high quality hearing aids and hearing assistive products,” said Matthew Moore, CEO of InnerScope Hearing Technologies. “We are proud to have Walmart.com choose our hearing aids and hearing assistive products for their customers. With the current average cost of hearing aids running about $5000.00, a set, it’s no wonder why, there is only 7 to 8 million Americans that currently use hearing aids when there are over 48 million that have reported some hearing loss and could benefit from using hearing aids or some hearing assistance. InnerScope’s agreement with Walmart, gives the company and Walmart the opportunity to sell the 48 million Americans an affordable alternative to the traditional high cost of hearing aids at 75% to 80% less than the current average cost. Not to mention, the revenue potential is off the charts for both the company and Walmart. Each person has two ears, that’s 96 million potential hearing aid sales,” continued Mr Moore.

“We know the cost of hearing aids is just too high for most people that need them. However, there is even a greater cost that very few ever know about. The “real” cost is much higher than the actual dollars spent. For those approximately 42 million Americans that suffer from hearing loss and could not afford to purchased hearing aids, are potentially at high risk and in-fact, could be jeopardizing their overall health and well-being. Proper auditory stimulation from the use of hearing aids may reduce health issues associated with of untreated hearing loss, including cognitive issues, such as Dementia and Alzheimer’s disease. We believe with Walmart.com as retailer of InnerScope’s hearing products, more people will recognize the need to treat their hearing issues sooner than later and thereby reducing unnecessary health risks, due to untreated hearing loss,” Mr Moore concluded

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Lagos Commences Screening of Newborns for Sickle Cell Disease

Published

on

sickle cell disease screening Lagos

By Modupe Gbadeyanka

The Lagos State government has kicked off an initiative to ensure that every newborn is screened for Sickle Cell Disease within 48 to 72 hours after birth using a simple heel-prick test.

It was gathered that babies identified as being at risk will immediately be placed on preventive care while awaiting confirmatory testing.

The Head of the Haematology Department at the Alimosho General Hospital, Dr Olubukola Orolu, revealed that an estimated 150,000 babies are born annually with Sickle Cell Disease in Nigeria, giving the country one of the highest SCD burdens globally.

She, however, applauded the Lagos State Government and the Clinton Health Access Initiative (CHAI) for introducing the state-wide newborn screening programme, describing it as a major step towards reducing childhood deaths associated with the disease.

The commencement of this scheme coincides with the 2026 World Sickle Cell Day, themed Young Voices Rising for Sickle Cell Disease – Closing the Survival Gap: Equity in Sickle Cell Disease.

It highlights the importance of listening to the experiences and aspirations of young people living with Sickle Cell Disease.

Mrs Orolu noted that SCD warriors are increasingly breaking barriers as advocates, leaders, students and change-makers, adding that their voices have continued to reshape the narrative through advocacy for equitable, patient-centred healthcare, self-care and experience sharing.

She, therefore, called for equal access to quality healthcare, survival opportunities and dignity for everyone living with Sickle Cell Disease.

Also commenting, the chief executive of Alimosho General Hospital, Dr Akinyele Akinlade, described Sickle Cell Disease as an inherited blood disorder that is not contagious, noting that individuals living with the condition are more susceptible to infections.

He advised SCD warriors to stay well hydrated, avoid stress, and protect themselves from extreme cold or heat, as these are common triggers of sickle cell crises, adding that these preventive measures can significantly reduce the frequency and severity of crises.

One of the participants, Ms Borokini Zainab, an SCD warrior and student nurse, expressed appreciation to the organisers for the enlightenment programme.

Sharing her personal journey, she spoke about the challenges of balancing recurrent pain crises with her academic pursuits and personal life. Despite moments of frustration, she encouraged fellow warriors not to lose hope.

“Don’t let sickle cell put you down. Be encouraged from within. Don’t let your dreams be shattered because of this,” she said, adding that her personal experience with Sickle Cell Disease inspired her to pursue a career in nursing so she could support others living with the condition.

Continue Reading

Health

Evon Labs Unveils Health-Tech Incubation Initiative HealthX Catalyst

Published

on

Evon Labs Isioma Udeozo HealthX Catalyst

By Aduragbemi Omiyale

A 12-week health-tech incubation programme tailored for early-stage founders in Nigeria has been introduced by an innovation and venture-building platform, Evon Labs.

This initiative, known as HealthX Catalyst, will help participants to create scalable, investable solutions for Africa’s urgent healthcare issues.

The programme is underway, with 12 selected founders nearing the final weeks of intensive incubation, ending with a Demo Day on June 24, 2026, at the UNDP innovation centre in Lagos, where the small business owners will present their solutions to an audience of investors, healthcare leaders, development organisations, and technology partners.

The initiative selects early-stage healthcare founders and immerses them in a structured 12-week development process. Throughout this period, participants receive personalised and group mentorship from seasoned professionals across the healthcare, technology, and business sectors.

They also receive structured support for startup development, including refining business models, developing value propositions, and validating markets.

Additionally, participants gain access to a network of healthcare practitioners, sector experts, and industry leaders, along with targeted investment-readiness assistance to prepare them to engage with investors and strategic partners after the programme.

The result is a cohort of founders who move through the programme not simply with a refined pitch, but with a validated business model, a stronger professional network, and a clear pathway to growth.

To accelerate the most promising solutions beyond the programme, monetary grants will be awarded to the top three founders to support product development, pilot implementation, market validation, and early-stage scaling.

It was learned that HealthX Catalyst was developed in response to a structural gap in the African health-tech ecosystem.

Across the continent, a growing number of entrepreneurs are building solutions to healthcare problems from access and diagnostics to service delivery and health data infrastructure. Yet many of these early-stage ideas fail to progress beyond concept, not for lack of vision, but for lack of structured support: mentorship, startup development frameworks, industry access, and early-stage funding pathways. HealthX Catalyst was built to provide exactly that.

“Africa does not have a shortage of healthcare innovators. What it has lacked is the infrastructure to turn its ideas into sustainable businesses. HealthX Catalyst is that infrastructure, a serious, structured programme designed to take founders from early-stage ideas to investable startups.

“What we are seeing from this first cohort is exactly what we set out to create: founders who are not just building products, but building businesses that can scale and create lasting impact,” the founder of Evon Labs, Ms Isioma Udeozo, said of the unveiling of HealthX Catalyst.

The partners of the programme are the United Nations Development Programme (UNDP), Odua Investment Company Limited (OICL), Washington University of St Louis, Missouri, Lagos State Employment Trust Fund (LSETF), and Brooks Insights.

Continue Reading

Health

Binance Promises $250,000 for Ebola in DR Congo, Uganda

Published

on

Binance

By Aduragbemi Omiyale

The sum of $250,000 in humanitarian funding is to be provided by Binance to support the frontline response to the ongoing Ebola disease outbreak in the Democratic Republic of Congo (DRC) and Uganda.

The cryptocurrency exchange said the funds would be used to enable rapid response in high-risk and underserved areas, where access to healthcare infrastructure, protective resources, and timely public health information remains limited.

The money will be shared equally between the Uganda Red Cross Society and Doctors Without Borders / Médecins Sans Frontières (MSF), supporting urgent interventions in affected and high-risk communities.

Binance’s contribution will help strengthen emergency medical care and treatment, community awareness and prevention campaigns, contact tracing and containment support, and the provision of sanitation supplies and protective equipment for frontline workers.

By supporting both immediate response activities and preventative education, Binance aims to contribute to reducing transmission and strengthening community resilience.

“Communities across Africa continue to show extraordinary resilience in the face of complex challenges, but frontline responders should not have to face crises like this alone,” the co-chief executive of Binance, Mr Richard Teng, said.

“The teams working to contain the Ebola disease outbreak are delivering vital, life-saving support under incredibly difficult conditions.

“We are proud to support both the Uganda Red Cross Society and Doctors Without Borders as they work to protect vulnerable populations, strengthen local response efforts, and deliver urgent care where it is needed most,” he added.

Also commenting, the Secretary General for the Uganda Red Cross Society, Mr Robert Kwesiga, said, “Strong partnerships are essential during public health emergencies since we are not able to manage the outbreak alone.

“The support from Binance comes in so timely and handy, and will help us respond more rapidly, reach more at-risk communities, and reinforce the frontline services needed to help contain the outbreak and save lives.”

The MSF Emergency Programme Manager, Trish Newport, while speaking on the initiative, said, “The number of cases and deaths we are seeing in such a short timeframe, combined with the spread across several health zones and now across the border, is extremely concerning. In Ituri, many people already struggle to access healthcare and live with ongoing insecurity, making rapid action critical to prevent the outbreak from escalating further.”

Caused by the Bundibugyo virus, for which there is no approved vaccine or treatment, this Ebola disease outbreak has placed acute pressure on already fragile health systems in eastern DRC and the wider region.

Local authorities, international agencies, and humanitarian organisations are racing to contain it and protect affected communities.

Binance’s support is intended to reinforce these efforts at a critical moment. It reflects the company’s broader commitment to supporting communities across Africa through programmes focused on education, financial inclusion, digital skills development, and community empowerment.

In this case, Binance is extending that commitment to urgent humanitarian and public health needs by working alongside trusted organisations with deep frontline expertise.

Continue Reading

Trending